➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for THEOCLEAR L.A.-260

Email this page to a colleague

« Back to Dashboard

Bulk Pharmaceutical API Sources for THEOCLEAR L.A.-260

Vendor Vendor Homepage Vendor Sku API Url
MolPort ⤷  Free Forever Trial MolPort-002-339-588 ⤷  Free Forever Trial
Hangzhou APIChem Technology ⤷  Free Forever Trial AC-12160 ⤷  Free Forever Trial
ABI Chem ⤷  Free Forever Trial AC1L3LQJ ⤷  Free Forever Trial
ChemMol ⤷  Free Forever Trial 30101964 ⤷  Free Forever Trial
TimTec ⤷  Free Forever Trial ST50411853 ⤷  Free Forever Trial
ISpharm ⤷  Free Forever Trial I14-62379 ⤷  Free Forever Trial
AKos Consulting & Solutions ⤷  Free Forever Trial AKOS015960702 ⤷  Free Forever Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.